Two analyses revealed widely varying treatments — and outcomes — for children with congenital lung malformations.
CS Mott Children's Hospital
Donated tumor tissue from a 5-year-old brain cancer patient uncovers the key and early role of a less-understood genetic mutation in the cancer’s fatal course.
FDA approves CAR T-cell therapy, a state-of-the-art immune-therapy trial to target childhood leukemia. Mott is the only certified treatment center in Michigan and one of a select few in the country to offer it.
Data show that the majority of neonatal epilepsy is linked to identifiable genetic causes, which may help guide treatment and family genetic counseling.
Even in low amounts, interruptions to parent-child time caused by digital technology are associated with greater child behavior problems, a new study suggests.
In light of advancing fetal diagnostic capabilities, a team of U-M physicians is working to improve the decision-making process for families facing complex decisions about their unborn child’s care.